Page last updated: 2024-10-28

go 6976 and Alzheimer Disease

go 6976 has been researched along with Alzheimer Disease in 2 studies

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koryakina, A1
Aeberhard, J1
Kiefer, S1
Hamburger, M1
Küenzi, P1
Zhu, G1
Wang, D1
Lin, YH1
McMahon, T1
Koo, EH1
Messing, RO1

Other Studies

2 other studies available for go 6976 and Alzheimer Disease

ArticleYear
Regulation of secretases by all-trans-retinoic acid.
    The FEBS journal, 2009, Volume: 276, Issue:9

    Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Carb

2009
Protein kinase C epsilon suppresses Abeta production and promotes activation of alpha-secretase.
    Biochemical and biophysical research communications, 2001, Jul-27, Volume: 285, Issue:4

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein

2001